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Background: Juvenile Idiopathic Arthritis (JIA) affects children and adolescents with both short-term and long-term
disability. These children also report lower health-related quality of life (HRQOL) compared to their healthy peers.
However, there seems to be some discrepancies between self- and parent-reports, and gender differences need to
be further studied. This study aims to describe HRQOL in girls and boys with JIA, and to explore gender differences
in self-reports compared to parent-reports of HRQOL in children with JIA.
Methods: Fifty-three children and adolescents with JIA (70% girls and 30% boys) with a median age of 14 years (8–
18 years), and their parents, participated in this cross-sectional study in Sweden. Data was systematically collected
prior to ordinary visits at a Pediatric outpatient clinic, during a period of 16 months (2009–2010). Disability was
assessed with the Childhood Health Assessment Questionnaire (CHAQ), and disease activity by physicians’
assessments and Erythrocyte Sedimentation Rate (ESR). The Pediatric Quality of Life Inventory 4.0 Generic Core
Scales (PedsQL) was used to assess self- and parent-reports of HRQOL in the child.
Results: In this sample of children with generally low disease activity and mild to moderate disability, more than
half of the children experienced suboptimal HRQOL, equally in girls and boys. Significant differences between self-
and parent-reports of child HRQOL were most evident among girls, with lower parent-reports regarding the girl’s
physical- and psychosocial health as well as in the total HRQOL score. Except for the social functioning subscale,
where parents’ reports were higher compared to their sons, there were no significant differences between boys-
and parent-reports.
Conclusions: More than half of the girls and boys experienced suboptimal HRQOL in this sample, with no gender
differences. However, there were differences between self- and parent-reports of child HRQOL, with most significant
differences found among the girls. Thus, differences between self- and parent-reports of child HRQOL must be
taken into account in clinical settings, especially among girls with JIA.
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The yearly incidence of Juvenile Idiopathic Arthritis
(JIA) in Sweden is about 15 per 100 000 children,
and JIA is more common among girls than boys [1].
Although JIA is a collective term for chronic rheum-
atic diseases in children, it is frequently used as one
diagnosis. JIA is an important cause of short-term and
long-term disability [2]. The disease affects physical* Correspondence: veronica.lundberg@vll.se
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reproduction in any medium, provided the orfunctioning and mental health, and also impact school
and home functioning [3]. As children reach adult-
hood, they face possible continuing disease activity,
medication-associated morbidity, life-long disability,
and an increased risk of emotional and social dysfunc-
tioning [3].
It has also been established that children with JIA re-
port lower health-related quality of life (HRQOL) as
compared to their healthy peers [3-9]. Quality of life
(QOL) is generally conceptualized as a broad concept,
addressing well-being across various domains. HRQOLral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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construct. However, there are a range of definitions, the-
ories, domains, and items associated with pediatric QOL
assessment [10]. In the present study, the following
HRQOL definition was utilised: ‘a multidimensional con-
struct covering physical, mental, social, and behavioural
components of well-being and function as perceived by
the patients, and/or individual feelings associated with
health’ [10]. The consequences of JIA seem to influence
HRQOL, with physical functioning being most affected
[3,9,11]. Disability and pain have been found to be the
most important determinants of physical and psycho-
social well-being, in a European and Latin American
study of HRQOL in JIA patients [9].
Instruments used to measure HRQOL can be condi-
tion-specific, generic, or chronic generic. The condition-
specific instruments address aspects related to a specific
condition and can be used to compare data from chil-
dren and adolescents with the same chronic medical
condition. Generic instruments are usable for assess-
ment in all children, whether they are healthy or suffer
from a medical condition [12]. Generic instruments for
chronic disease are usable in children and adolescents
who suffer from any chronic medical condition, and per-
mit comparisons across different medical conditions
while taking into account specific areas affected by a
chronic disease [13]. Pediatric HRQOL-instruments
must be sensitive to cognitive development and can in-
clude both child self-reports and parent proxy-reports
[14]. However, it is important to obtain self-reports
whenever possible, as there seem to be some differences
between self- and parent-reports of HRQOL in children
[14-16].
It is not sufficient to know if a medical treatment can
save lives or hold diseases at bay. How the treatment
affects patient’s HRQOL is also important in medical
evaluations [17]. Health care professionals need insight
into the HRQOL of patients with JIA, to better under-
stand their overall health situation, and thus, have a bet-
ter basis for performing targeted interventions. HRQOL
in children and adolescents with JIA in northern Sweden
has not earlier been systematically studied. Studies
examining gender discrepancies between self- and
parent-reports in JIA also seem to be lacking. Our as-
sumption was that girls would report lower HRQOL
than boys, as earlier findings from a community-based
study indicated that, from early adolescence females de-
velop internalizing symptoms (e.g. depression) at higher
rates than males [18]. We also assumed that both girls
and boys equally would report higher HRQOL in com-
parison to parent-reports of their HRQOL, as found in
other studies [15,19]. In the light of the discrepancies be-
tween self- and parent-reports, also gender differences
need to be further studied.Aim
The aim of this study was to describe HRQOL in girls
and boys with JIA in Sweden, and to explore gender dif-
ferences in self-reports compared to parent-reports of
HRQOL in children with JIA.
Methods
Study design and study population
A cross-sectional questionnaire survey approaching chil-
dren and adolescents registered with a JIA diagnosis at
the Department of Child and Adolescents Medicine,
Norrland’s University Hospital in Umeå, Sweden. The
department serviced all children with JIA in the county
of Västerbotten and the study population included all 8–
18 year olds (n = 69) with routine outpatient appoint-
ments between September 2009 and December 2010.
Participants
Out of the 69 eligible children identified through clinical
appointment schedules, 56 children and their parents
agreed to participate in the study. Three were excluded
due to missing parent-reports and therefore 53 children
(37 girls and 16 boys) remained to be studied. Of the
participating parents, 37 were mothers, 12 fathers, and
in four families, the mothers and fathers jointly com-
pleted the questionnaires. The reason for declining par-
ticipation was unknown in six families, four parents
expressed that the child only had minor problems due to
the disease, two failed to participate due to a lack of
time, and one child was transitioned into adult care. Eli-
gibility criteria was child age 8 to 18 years and a
JIA diagnosis as defined by the International League
of Associations for Rheumatology (ILAR) classification
criteria [20].
Measures
HRQOL was assessed using the Pediatric Quality of Life
Inventory 4.0 Generic Core Scales (PedsQL) [14]. This
generic questionnaire consisted of 23 items combined into
physical, emotional, social, and school functioning scales.
A physical health summary score was based on eight items
and equal to the physical functioning scale. A psychosocial
health summary score was based on the 15 items from the
emotional, social and school functioning scales. Mean
values were computed for each scale. In this study the
self- and parent-report forms for ages 8 to 12 years, and
13 to 18 years were used. The parent-report forms
assessed the parent’s perception of HRQOL in their chil-
dren and were constructed to directly parallel the self-
report forms. Recall time was one month and a five point
response scale was utilized with alternatives between 0
(never a problem) and 4 (almost always a problem). Items
scores were reversed and linearly transformed to a 0 to
100 scale (0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0), with higher







Age at study visit, years Md (range) 14 (8–18) 14 (10–18) 0.612
CHAQ Disability Index2, n (%)
No-mild 12 (32) 5 (31) 0.841
Mild- moderate 9 (24) 5 (31)
Moderate 12 (32) 6 (37)
Severe 3 (8)
Missing 1 (3)
Pain VAS3, 0–100 Md (range) 31 (0–93) 51 (0–99) 0.377
Well-being VAS4, 0–100 Md (range) 21 (0–99) 28 (0–100) 0.488
School absence days5, Md (range) 0 (0–14) 0 (0–6) 0.258
Physical education attendance, n (%)
Always 12 (32) 9 (56) 0.105
Sometimes 15 (41) 5 (31)
Not at all 6 (16) 2 (12)
Not relevant 3 (8)
Missing 1 (3)
Disease duration, years Md (range) 5 (0–16) 2 (0–13) 0.054
ESR6, mm/hour Md (range) 5 (2–31) 4 (2–35) 0.175
Disease activity categories, n (%)
No 12 (32) 9 (56) 0.221
Low 20 (54) 5 (31)
Moderate 4 (11) 2 (12)
High 0 0
Missing 1 (3)
Use of medications7, n (%)
DMARD 24 (65%) 7 (44%) 0.704
NSAID 25 (68%) 8 (50%) 0.416
Biologic medication 4 (11%) 0
Corticosteroid therapy 7 (19%) 0
1Mann Whitney U test.
2Childhood Health Assessment Questionnaire Disability Index.
3Visual Analogue Scale for pain during the past week; 0 = no pain and
100 = very severe pain.
4Visual Analogue Scale for assessment of overall well-being; 0 = very good and
100 = very bad.
5Number of days absent from school the last two months, due to rheumatic
disease.
6Erythrocyte Sedimentation Rate.
7Disease modifying anti-rheumatic drug (DMARD), Non-steroid anti-inflammatory
drug (NSAID). Participants might have more than one medication.
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HRQOL was defined as a PedsQL total mean scale score
<78.6 [8]. Reliability and validity has been tested in diverse
samples of healthy children and pediatric patients with
acute or chronic conditions, and PedsQL has been proven
reliable, valid and sensitive to disease severity, and respon-
sive to changes in JIA [14]. The Swedish version of
PedsQL has also been proved to have acceptable reliability
and validity [21]. However, construct validity was ques-
tioned for the Swedish proxy form, but not for the self-
report form [21].
Disability was measured by the Childhood Health As-
sessment Questionnaire (CHAQ) [22]. The CHAQ com-
prised 30 items and measured eight functional areas:
dressing and grooming, arising, eating, walking, hygiene,
reach, grip, and activities. Three components were
assessed in each area: a) the degree to which daily func-
tions were difficult to perform, b) the use of special aids
or devices, and c) activities for which assistance of an-
other person was required. Each question was scored on
a four point scale between 0 (no difficulty) and 3 (unable
to do). The question with the highest score determined
the score for that functional area. If aids or devices
were used or help was needed to complete tasks in a
certain area, a minimum score of two points were
recorded for the corresponding functional area. The
scores for each of the eight functional areas were aver-
aged to calculate a Disability Index (DI), ranging from 0
(no disability) to 3 (disabled) [22]. The cut-off levels for
mild, mild-to-moderate, and moderate disability have
been suggested at medians 0.13, 0.63, and 1.75, respect-
ively [23]. The CHAQ also assessed pain and overall
well-being measured by two 0–100 mm Visual
Analogue Scales (pain VAS and well-being VAS), num-
ber of days absent from school the last two months due
to JIA, and attendance at physical education classes,
categorized into three groups; 1 = always, 2 = sometimes,
and 3 = not at all [22]. The original CHAQ as well as
the Swedish version have been shown to be reliable and
valid tools for functional, physical, and psychosocial
assessments in children with JIA [22,24,25].
Disease duration in years was estimated based on data
registered in the medical records. If date of diagnosis
was missing, the 1st of the month was registered. If
month was missing the 1st of January the year of diagno-
sis was registered.
Disease activity was measured by Erythrocyte Sedimen-
tation Rate (ESR) in mm/hour and by the responsible
physician’s assessment of disease activity categorized
into; no-, mild-, moderate-, or high disease activity. Mod-
erate disease activity indicated need for changes of med-
ical therapy, mild was defined between no activity and
moderate activity, and high activity indicated severe im-
munologic and clinical activity.Medications were registered in four categories: 1) Dis-
ease modifying anti-rheumatic drug (DMARD) e.g. cyclo-
sporine, azathioprin, methotrexate, hydroxychoroquine,
and sulphasalazine, 2) Non-steroid anti-inflammatory
drug (NSAID) e.g. diclophenac, ibuprofen, naproxen,
ketoprofen, 3) Biological medication e.g. etanercept, ada-
limumab, infliximab, anakinra and rituximab, and 4) Cor-
ticosteroid therapy (Table 1).
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Families who gave consent to participate in the study
completed several questionnaires as parts of a larger
study, of which the current study report HRQOL results
based on the PedsQL questionnaire. The questionnaires
were answered at the clinic prior to a scheduled visit to
a Pediatric rheumatologist. Parents and children com-
pleted the PedsQL separately, with a research assistant
available for the child. The CHAQ was used routinely in
clinical practice, and was answered by children and their
parents at home before visiting the Pediatric outpatient
clinic. The PedsQL has been reported to take approxi-
mately five minutes to complete [14] and the CHAQ less
than ten minutes [22]. Estimated time to complete all
the study-questionnaires was 20–40 minutes for each
child and another ten minutes for the CHAQ to be com-
pleted at home before the visit. All questionnaires were
numbered with a study-ID, and after completion placed
in a locked box, available only for the researcher who
was responsible for the study. Disease activity was
assessed by the Pediatric rheumatologist.
Ethical considerations
Informed consent was given by each participant. Report-
ing was done on group level without revealing results on
an individual level. Ethical approval was obtained from
the regional ethical review board in Umeå, Sweden (Dnr
09-070 M).
Statistics
Data from girls and boys were analyzed separately. Results
of the descriptive analysis were presented as median and
range or numbers (n) and percentages (%). Results regard-
ing HRQOL were presented by mean, standard deviation
(SD), median (Md), and range. Mann Whitney U test was
used to analyse gender differences, and Wilcoxon signed-
rank test for analysis of differences between self- and par-
ent-reports. The analysis was performed by use of the
Statistical Package for the Social Sciences (SPSS) version
18 and 19. Statistical significance was defined at p< 0.05.
Results
Sample characteristics
Median age for the participating children was 14 years
(range 8–18 years) and their disease activity was gener-
ally low. Girls and boys did not differ significantly in any
of the assessed characteristics (Table 1). The following
diagnoses were identified among the participants; oli-
goarthritis, n = 19 (36%), polyarticular arthritis RF-posi-
tive, n = 9 (17%), enthesetis-related arthritis, n = 8 (15%),
unspecified arthritis, n = 7 (13%), psoriatic arthritis, n = 6
(11%), polyarticular arthritis RF-negative, n = 2 (4%), and
systemic arthritis, n = 2 (4%). In ten of the girls, at least
one additional diagnosis was reported by the child or theparent, i.e. uveitis, overweight, asthma, dermatitis, Turn-
ers syndrome, celiac disease, Crohn’s disease, and atten-
tion-deficit/hyperactivity disorder. Likewise, among six
of the boys at least one additional diagnosis was
reported, i.e. thyroid gland disease, asthma, allergy, panic
disorder, Raynaud’s syndrome and lactose intolerance.Health-related quality of life
This sample of children with JIA reported a physical
health mean score of 68.31 (SD 20.72), a psychosocial
health mean score of 78.66 (SD 16.88), and a total
HRQOL mean score of 75.06 (SD 16.28). The parental
mean score of the children’s physical health was 66.01
(SD 20.49), the psychosocial health mean score was
73.83 (SD 19.54), and the PedsQL total mean score was
71.14 (SD 18.66). Suboptimal HRQOL was reported by
29 of the children (55%) and 31 of the parents (59%). No
gender differences were found in the children’s self-
reports. Significant differences between self- and parent-
report were most evident among girls, with lower
parent-reports compared to self-reports regarding
physical- and psychosocial health as well as in the total
HRQOL score. There were no significant differences be-
tween self- and parent ratings in boys, except for parent-
reports of their son’s social functioning being higher
than the corresponding self-reports (Table 2). In this
subscale, the parents of the boys also reported signifi-
cantly higher scores compared to the girls’ parents
(p = 0.04), but this was not found in any of the other
subscales.Discussion
Our main finding was that more than half of the chil-
dren experienced suboptimal HRQOL, based on both
self- and parent-reports. No gender differences were
found in self-reports of any PedsQL subscale, nor in the
total HRQOL scores. On the other hand, there were sig-
nificant differences between self- and parent-reports,
primarely evident among girls.
Children with no, or very mild, clinical JIA-symptoms
have been found to experience suboptimal HRQOL,
defined as PedsQL total scale score <78.6 [8]. On the
other hand, another study showed that JIA patients with
inactive polyarticular disease reported HRQOL similar
to that of healthy controls [7]. However, our results
showing that children and parents rated physical func-
tioning the worst, and social functioning the best, was
comparable to results found in an earlier psychometric
study [26].
In this study we used PedsQL 4.0, a generic question-
naire which enables comparisons across pediatric
patients and healthy populations. A disease-specific and/
or chronic-generic questionnaire might have given more
Table 2 Health-related quality of life measured by PedsQL 4.0 Generic Core Scales in children with JIA aged 8–18 years and differences in self- and parent-
reports
Girls n = 37 Mean (SD)
Median (range)
Girls’ parents n= 37 Mean
(SD) Median (range)
p-value1 Boys n = 16 Mean (SD)
Median (range)
Boys’ parents n =16 Mean
(SD) Median (range)
p-value1
Physical health 70.82 (17.98) 68.75 (26.79-100) 65.49 (20.73) 67.86 (31.25-100) 0.028 62.50 (25.72) 65.62 (15.63-100) 67.21 (20.52) 65.62 (18.75-100) 0.116
Emotional functioning 79.86 (21.06) 85.00 (30.00-100) 71.59 (22.78) 75.00 (15.00-100) 0.009 76.48 (23.78) 85.00 (10.00-100) 74.37 (25.02) 77.50 (0.00-100) 0.623
Social functioning 86.69 (14.51) 90.00 (45.00-100) 76.76 (18.49) 80.00 (25.00-100) 0.001 79.37 (19.91) 80.00 (15.00-100) 85.94 (19.25) 90.00 (25.00-100) 0.027
School functioning 71.65 (21.03) 80.00 (25.00-95.00) 67.89 (22.60) 75.00 (20.00-100) 0.135 75.00 (18.07) 80.00 (25.00-100) 73.44 (23.57) 77.50 (5.00-100) 0.637
Psychosocial health 79.40 (15.91) 81.67 (48.33-98.33) 72.06 (18.90) 71.67 (30.00-100) 0.002 76.94 (19.37) 78.75 (16.67-100) 77.92 (20.99) 79.17 (10.00-100) 0.691


















Lundberg et al. Pediatric Rheumatology 2012, 10:33 Page 6 of 8
http://www.ped-rheum.com/content/10/1/33detailed information about other aspects of health pro-
blems caused by a chronic disease like JIA.
Regarding parent–child agreement, a review study con-
cluded that parents of healthy children tended to report
higher scores of HRQOL than the children themselves.
On the other hand, parents of children with different
health conditions tended to underestimate the child’s
HRQOL [19]. This is in accordance with our findings
among girls, i.e. lower parent-reports of HRQOL com-
pared to corresponding self-reports. This was also found
in another study among children with JIA [15]. However,
in our study the parents of the boys tended to report
higher scores than their sons with regard to physical
health, social functioning, psychosocial health and total
HRQOL. These differences were not statistically signifi-
cant except in the social functioning subscale. In contrast,
in another study of children with JIA, the authors found
no significant differences between the parents and their
children’s evaluation of the child’s quality of life [27].
There are varying findings in the literature on health-
ratings in children with JIA. In one sample of adolescent
with JIA, a wide variation was found in parent–child
agreement for different health-related variables including
pain, general health, functional ability, and HRQOL. Par-
ent–child agreement was evidently better for all these
variables when they were estimated to be mild or severe
and variations were most pronounced for more mid-
range outcomes [16]. This was supported by another
study showing a trend toward better agreement between
self- and parent-reports among children with an active
disease than among those with an inactive disease [7]. It
could have been the case in our study sample with gen-
eral low disease activity. However, there were no gender
differences in disability or disease activity in our study,
and therefore this could not explain the differences in
girls and boys child–parent- reports in our sample. Pre-
vious findings show that physical health is particularly
important in rheumatic diseases, and the parent–child
agreement on this subscale seems to be high [19,28]. In
our study significant differences were found in physical
health between child- and parent reports among the
girls, but not the boys.
No other studies of gender differences in HRQOL-
reports among children with JIA and their parents have
been performed, as far as we know. Our results might be
one additional explanation for some of the divergent
findings in child-parents reports, since the results seem
to point out some gender differences. The results indi-
cating parent–child differences to be more evident
among girls compared to the boys, was somewhat sur-
prising to us, as we did not expect any gender differ-
ences in that regard. Instead, we expected longer disease
duration to increase parents’ and children’s awareness
and consensus of impact of the disease on life situation.However, the girls seemed to have close to significant
longer disease duration compared to the boys. A number
of other variables not included in this study may have
affected the parent–child reports, e.g. mental health and
comorbidity. Mental health among our participants may
have impacted the results, as adolescents with JIA, who
report depressive symptoms, seem to be more likely to
disagree with their parents in ratings of disability, pain,
and well-being [29]. In this sample there were a remark-
able number of self- and parent-reported additional
diagnoses among both sexes (10 out of 37 girls and 6
out of 17 boys). As both girls (27%) and boys (35%) had
additional diagnosis, it is uncertain whether comorbidity
may have influenced the differences between parent and
child report. However, the high degree of comorbidity in
this sample might affect the study results generalizability
for the whole JIA population. Disability measured by the
CHAQ was found to be mild to moderate in our sample,
which is in accordance with findings in other studies of
children with JIA [9,11,15,16,30].
A satisfying number of children (80%) agreed to par-
ticipate in this study. Oligoarthritis was the most com-
mon JIA sub-diagnosis in our sample, which is in
accordance with a Nordic JIA incidence study [31]. The
fact that four parents expressed that the child did not
have much problems due to the disease and therefore
declined to participate might have biased our results
slightly towards lower ratings of HRQOL. In terms of
generalizability, our sample was relatively small and pre-
dominantly female, which is similar to the epidemiology
of JIA [32]. This fact makes it more difficult to draw reli-
able conclusions, but not as much among the girls as
among the boys. Because of the small sample size, it was
not appropriate to analyse sub-groups for both age and
gender, which would have given additional age-specific
information about the study population.
The differences between child- and parent-reporting
emphasize the importance of health care professionals
obtaining information about children’s health situation
from both parents and children [15]. Although self-
report is considered the gold standard for HRQOL as-
sessment, the parents’ perception of their child’s
HRQOL influences health care utilization. It is therefore
essential to increase the knowledge about the relation-
ship between parent- and child-reporting [17]. Relying
solely on parent-reports will only partly inform the
health professionals [16]. However, children with JIA
have reported difficulties in communicating their pro-
blems to health professionals [15]. It is therefore of great
importance to support children’s ability to self-report
verbally and in writing within pediatric care. PedsQL
was simple to complete for the child at the outpatient
clinic, but to make the instrument feasible for clinical
use; a faster method for generating scale scores is
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stand gender differences in child–parent reports of
HRQOL in children with JIA, for example in larger sam-
ples and through in-depth interviews.
Conclusions
More than half of the girls and boys experienced sub-
optimal HRQOL in this sample, with no gender differ-
ences. However, significant differences between self- and
parent-reports of child HRQOL were shown, primarily
among the girls. Thus, differences between child- and
parent-reports of HRQOL must be taken into account in
clinical settings, especially among girls with JIA.
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